Acuta Capital Partners, LLC ENLIVEN THERAPEUTICS INC Transaction History

Acuta Capital Partners, LLC

  • $52.7 Million
  • Q1 2025
Number of Shares
265,269
Previous 267,368 0.79%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
N/A
-2,099 Reduced 0.79%
265,269 $0
Q4 2024

Feb 14, 2025
SELL
N/A
-29,000 Reduced 9.79%
267,368 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-101,330 Reduced 25.48%
296,368 $0
Q2 2024

Aug 14, 2024
BUY
N/A
1,599 Added 0.4%
397,698 $0
Q1 2024

May 15, 2024
BUY
N/A
272,223 Added 219.75%
396,099 $0
Q4 2023

Feb 14, 2024
BUY
N/A
20,276 Added 19.57%
123,876 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-900 Reduced 0.86%
103,600 $0
Q2 2023

Aug 14, 2023
BUY
N/A
73,521 Added 237.33%
104,500 $0
Q1 2023

May 15, 2023
BUY
N/A
30,979 New
30,979 $0
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email